Ketanserin (S2-receptor blocking agents), hypertension and chronic alcoholism. 1986

A De Lorenzo, and M Ceccanti, and M Romeo, and M Pisculli, and M G Di Giovanni, and A Lais, and G Assogna, and F C Valgiusti

Ketanserin is a pure antagonist of serotonin S2-receptors, in blood vessels, platelets and bronchial tissue. Ketanserin has been suggested as hypotensive drug in man, but it shows as well a specific activity on platelet aggregation. An increased incidence of hypertension, of unknown origin, has been found in patients with chronic alcoholism: hypotheses have been made upon an increased incretion of catecholamines and a greater sensitivity of blood vessels' receptors to their action. The data from the present study of eleven patients show that these subjects had an increased platelet activity and ketanserin administration was effective in allowing both the blood pressure levels and platelet activity to resume their normal range. This drug is thus suggested, for its pharmacological properties, as an elective medication for hypertensive patients with chronic alcoholism.

UI MeSH Term Description Entries
D006973 Hypertension Persistently high systemic arterial BLOOD PRESSURE. Based on multiple readings (BLOOD PRESSURE DETERMINATION), hypertension is currently defined as when SYSTOLIC PRESSURE is consistently greater than 140 mm Hg or when DIASTOLIC PRESSURE is consistently 90 mm Hg or more. Blood Pressure, High,Blood Pressures, High,High Blood Pressure,High Blood Pressures
D007650 Ketanserin A selective serotonin receptor antagonist with weak adrenergic receptor blocking properties. The drug is effective in lowering blood pressure in essential hypertension. It also inhibits platelet aggregation. It is well tolerated and is particularly effective in older patients. 3-(2-(4-(4-Fluorobenzoyl)piperidinol)ethyl)-2,4(1H,3H)-quinazolinedione,R-41,468,R-41468,R 41,468,R 41468,R41,468,R41468
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D010880 Piperidines A family of hexahydropyridines.
D001794 Blood Pressure PRESSURE of the BLOOD on the ARTERIES and other BLOOD VESSELS. Systolic Pressure,Diastolic Pressure,Pulse Pressure,Pressure, Blood,Pressure, Diastolic,Pressure, Pulse,Pressure, Systolic,Pressures, Systolic
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000437 Alcoholism A primary, chronic disease with genetic, psychosocial, and environmental factors influencing its development and manifestations. The disease is often progressive and fatal. It is characterized by impaired control over drinking, preoccupation with the drug alcohol, use of alcohol despite adverse consequences, and distortions in thinking, most notably denial. Each of these symptoms may be continuous or periodic. (Morse & Flavin for the Joint Commission of the National Council on Alcoholism and Drug Dependence and the American Society of Addiction Medicine to Study the Definition and Criteria for the Diagnosis of Alcoholism: in JAMA 1992;268:1012-4) Alcohol Abuse,Alcoholic Intoxication, Chronic,Ethanol Abuse,Alcohol Addiction,Alcohol Dependence,Alcohol Use Disorder,Abuse, Alcohol,Abuse, Ethanol,Addiction, Alcohol,Alcohol Use Disorders,Chronic Alcoholic Intoxication,Dependence, Alcohol,Intoxication, Chronic Alcoholic,Use Disorders, Alcohol

Related Publications

A De Lorenzo, and M Ceccanti, and M Romeo, and M Pisculli, and M G Di Giovanni, and A Lais, and G Assogna, and F C Valgiusti
November 1984, British journal of clinical pharmacology,
A De Lorenzo, and M Ceccanti, and M Romeo, and M Pisculli, and M G Di Giovanni, and A Lais, and G Assogna, and F C Valgiusti
January 1988, Journal of cardiovascular pharmacology,
A De Lorenzo, and M Ceccanti, and M Romeo, and M Pisculli, and M G Di Giovanni, and A Lais, and G Assogna, and F C Valgiusti
November 1987, Chest,
A De Lorenzo, and M Ceccanti, and M Romeo, and M Pisculli, and M G Di Giovanni, and A Lais, and G Assogna, and F C Valgiusti
March 1987, International journal of cardiology,
A De Lorenzo, and M Ceccanti, and M Romeo, and M Pisculli, and M G Di Giovanni, and A Lais, and G Assogna, and F C Valgiusti
June 1990, Ugeskrift for laeger,
A De Lorenzo, and M Ceccanti, and M Romeo, and M Pisculli, and M G Di Giovanni, and A Lais, and G Assogna, and F C Valgiusti
January 1984, Lancet (London, England),
A De Lorenzo, and M Ceccanti, and M Romeo, and M Pisculli, and M G Di Giovanni, and A Lais, and G Assogna, and F C Valgiusti
January 1984, Clinical and experimental hypertension. Part A, Theory and practice,
A De Lorenzo, and M Ceccanti, and M Romeo, and M Pisculli, and M G Di Giovanni, and A Lais, and G Assogna, and F C Valgiusti
June 1983, Archives internationales de pharmacodynamie et de therapie,
A De Lorenzo, and M Ceccanti, and M Romeo, and M Pisculli, and M G Di Giovanni, and A Lais, and G Assogna, and F C Valgiusti
May 1992, Archives of ophthalmology (Chicago, Ill. : 1960),
A De Lorenzo, and M Ceccanti, and M Romeo, and M Pisculli, and M G Di Giovanni, and A Lais, and G Assogna, and F C Valgiusti
January 1985, Journal of cardiovascular pharmacology,
Copied contents to your clipboard!